| Closed |
S0127 |
GASTRIC AND GE JUNCTION |
6/1/2002 |
8/15/2003 |
88% |
|
Published
|
| Closed |
SWOG-9444 |
GI TUMOR REPOSITORY |
4/15/1997 |
9/1/2004 |
|
|
|
| Closed |
S0502 |
GIST Ph III imatinib with or without bevacizumab |
4/15/2008 |
10/1/2009 |
2% |
|
Published
|
| Closed |
SWOG-7969 |
Hepatic Infusion and Systemic Combination Chemotherapy in the Treatment of Unresectable Hepatoma |
10/18/1979 |
3/30/1983 |
|
|
|
| Closed |
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415) |
High Risk Resectable Colon |
12/1/1994 |
12/15/1999 |
71% |
|
Published
|
| Closed |
S9700 |
PANCREAS |
9/15/1997 |
6/19/2001 |
90% |
|
Published
|
| Closed |
S9924 |
PANCREAS |
6/1/2000 |
6/1/2001 |
97% |
|
Published
|
| Closed |
S0107 |
PANCREAS |
7/1/2001 |
6/1/2003 |
100% |
|
Published
|
| Closed |
S0727 |
Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 |
3/1/2008 |
9/1/2010 |
100% |
|
Published
|
| Closed |
S0205 |
PANCREATIC |
1/1/2004 |
4/1/2006 |
100% |
|
Published
|
| Closed |
S2001 |
Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects |
12/4/2020 |
10/23/2025 |
83% |
|
|
| Closed |
S1505 |
Perioperative FOLFIRINOX vs Gem/nab-Pac for Resectable Panc Adeno |
10/12/2015 |
|
98% |
|
|
| Closed |
S1313 |
Ph Ib/II Rando mFOLFIRINOX+PEGPH20 vs mFOLFIRINOX Alone in Good PS Met Pancreatic Adenocarcinoma |
1/6/2014 |
|
73% |
|
|
| Closed |
S1005 |
Ph II MK-2206 gastric and GEJ |
1/1/2011 |
5/1/2013 |
100% |
|
Published
|
| Closed |
S0713 |
Ph II Rectal Pre-Operative ChemoRT |
2/1/2009 |
4/15/2013 |
94% |
|
Published
|
| Closed |
S0941 |
Phase II Cholangiocarcinoma with Sorafenib + Erlotinib |
4/15/2010 |
9/15/2011 |
73% |
|
Published
|
| Closed |
S1201 |
Phase II Rando Trt Based on ERCC1 for Advanced/Met Gastric Ca or Gastroesophageal Junction (GEJ) Ca |
2/8/2012 |
4/1/2015 |
95% |
|
|
| Closed |
SWOG-8823 |
Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL2) in Patients with Colorectal Carcinoma |
4/1/1989 |
11/15/1990 |
14% |
|
|
| Closed |
SWOG-8630 |
Phase II Study of Recombinant DNA Gamma Interferon in Advanced Colorectal Cancer |
5/15/1987 |
11/15/1988 |
|
|
Published
|
| Closed |
SWOG-8626 |
Phase II Study of Recominbant DNA Gamma Interferon in Advanced Cancer of the Pancreas |
5/15/1987 |
11/15/1988 |
|
|
Published
|
